Submit Deal

CAPSTAN THERAPEUTICS

HQ - San Diego

Summary

Capstan Therapeutics is a biotechnology company focused on developing in vivo cell reprogramming therapies using its proprietary CellSeeker tLNP platform.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 138 M

Avg. Deal Size£ 138 M

Market Context

Senior Management

Laura Shawver
President and CEO

Sort

ten bridge communications

HQ - Boston

pr advisors (2)

2 Shared Deals

2 For

£ 138 M

Total Value

centerview partners

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

n/a

Total Value

cooley

HQ - Palo Alto

legal advisors (1)

1 Shared Deal

1 For

n/a

Total Value

h/advisors abernathy

HQ - New York

pr advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

gibson dunn & crutcher

HQ - Los Angeles

legal advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

ropes & gray

HQ - Boston

legal advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy